Personalized MTM Personalized MTM powered by MedWise Advisor®
Long before the announcement of the Enhanced MTM Model, Tabula Rasa HealthCare (TRHC), an innovator in enhanced MTM services, has been providing PDPs with its MedWise Advisor application for personalized MTM services.
Under the Model, however, the personalized MTM services offered by TRHC are now eligible for reimbursement by CMS – and for additional performance-based payments.
MedWise Advisor® is a proprietary cloud-based medication safety platform unlike any other. Rather than assessing drug-drug interactions, MedWise Advisor uses a proprietary technology-based “hub-and-spoke” system (designed by clinicians and academics) to evaluate a large array of pharmacy safety vectors, at a beneficiary-specific level, to improve the safety and efficacy of an individual’s medication regimen.
The Medication Risk Mitigation Matrix™ (Pat. Pending), which lies at the heart of MedWise Advisor, has been proven to reduce hospitalizations, readmissions, falls, medication-related errors – and to improve overall quality and reduce costs.
If you are a PDP operating in any one or more of the following 5 Part D Regions, you may be eligible to participate in the Model. TRHC is interested to assist in the design and implementation of a compliant, enhanced MTM program:
Region 7 (Virginia)
Region 11 (Florida)
Region 21 (Louisiana)
Region 25 (Iowa, Minnesota, Nebraska, North Dakota, South Dakota, Wyoming)